Movement disorders clinical practice
Effects of MAO-B Inhibitors on Cognition in Patients with Parkinson's Disease: A Systematic Network Meta-Analysis.
Seon-Min Lee, Sung Ryul Shim, Yu Jin Jung, Taeho Greg Rhee, Kyum-Yil Kwon
Published: 202610.1002/mdc3.70520
Abstract
BACKGROUND: Parkinson's disease (PD) is a neurodegenerative disorder accompanied by cognitive impairment, which increases a risk of dementia as the condition progresses. Although monoamine oxidase B (MAO-B) inhibitors, such as selegiline, rasagiline…
Preview only. Read the full abstract at the source